Cargando…
Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells
Secondary resistant mutations in cancer cells arise in response to certain small molecule inhibitors. These mutations inevitably cause recurrence and often progression to a more aggressive form. Resistant mutations may manifest in various forms. For example, some mutations decrease or abrogate the a...
Autores principales: | Hamid, Abdulaziz B., Petreaca, Ruben C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226513/ https://www.ncbi.nlm.nih.gov/pubmed/32283832 http://dx.doi.org/10.3390/cancers12040927 |
Ejemplares similares
-
Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers
por: Hamid, Abdulaziz B., et al.
Publicado: (2022) -
KAT5 histone acetyltransferase mutations in cancer cells
por: L Hardison, Kimberly, et al.
Publicado: (2022) -
Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
por: Rasheed, Shayaan, et al.
Publicado: (2023) -
Mutation Spectra of the MRN (MRE11, RAD50, NBS1/NBN) Break Sensor in Cancer Cells
por: McPherson, Matthew T., et al.
Publicado: (2020) -
Small molecule inhibitors targeting the cancers
por: Liu, Gui‐Hong, et al.
Publicado: (2022)